Intraocular Lymphoma: Clinical Trials

165 trials for Intraocular Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

109 completed, 24 terminated, 10 unknown, 10 withdrawn. 75 Phase 1, 40 Phase 2, 21 Not applicable, 14 Phase 3, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 175Completed 58, Terminated 13, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 240Completed 28, Terminated 5, Withdrawn 4, Unknown 2, Recruiting 1
Not applicable21Completed 10, Terminated 4, Withdrawn 4, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 314Completed 11, Unknown 3
Early Phase 13Completed 2, Terminated 1

Follow Intraocular Lymphoma: new trials by email Literature Review of Intraocular Lymphoma trials Research Report on Intraocular Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post-Market Clinical Follow-Up Study on the Rotational Stability of an Intraocular Lens After Cataract Surgery
IOL, Cataract
Not yet recruitingRayner Intraocular Lenses Limited922026-11-012026-09-10
Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery
Atropine Eye drops - Pediatric Cataract, IOL Implantation
Not applicableNot yet recruitingCairo University502026-02-012026-01-23
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
No Intervention: Observational Cohort - Uveitis, Scleritis and Episcleritis
Active not recruitingSingapore National Eye Centre2002025-08-192025-09-16
Effect of Vitamin C Supplementation in Corneal Endothelial Damage in Phacoemulsification of Patients with Hard Cataracts
Oral Vitamin C, Placebo - Endothelial Cell Loss, Corneal, Cataract and Intraocular Lens (IOL) Surgery
Not applicableRecruitingUniversitas Indonesia1202024-12-072025-01-17
Clinical Outcomes of Patients with LAL+ in At Least One Eye
Light Adjustable Lens+ - IOL, Cataract
Enrolling by invitationFrank A. Bucci, Jr., M.D.252024-10-162024-10-21
ZR-MTX for PIOL Phase II Trial
Methotrexate, Rituximab (R), Zanubrutinib - Primary Intraocular Lymphoma
Phase 2RecruitingPeking Union Medical College Hospital472024-10-102026-09-04
Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens
Phacoemulsification with enhanced monofocal IOLs - Presbyopia, IOL, Cataract
CompletedDemocritus University of Thrace622024-04-012026-02-27
Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma
Vitreoretinal Lymphoma
RecruitingVinodh Kakkassery, MD2202023-06-012025-07-23
Mutation Detection for VRL
mutation test - Vitreoretinal Lymphoma, Uveitis
UnknownSun Yat-sen University402021-11-102021-11-15
Evaluation of Axial Stability of Two Models of Intraocular Lenses in Patients With an Eye Length More Than 26 mm
IOL Clareon AutonoMe, IOL Hoya iSert 251 - Cataract Senile, Myopia, High-Grade
Not applicableCompletedThe S.N. Fyodorov Eye Microsurgery State Institution782021-10-012024-04-23
Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma
Methotrexate, Rituximab, Lenalidomide - Primary Intraocular Lymphoma
Phase 2UnknownPeking Union Medical College Hospital422018-11-152019-10-09
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
rituximab, lenalidomide, romidepsin - B-cell Adult Acute Lymphoblastic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
Phase 1 / Phase 2WithdrawnMayo Clinic2016-10-012016-08-11
Clinical Evaluation of Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery
AT TORBI 709M - Iol, Astigmatism
Not applicableUnknownSeoul National University Hospital202015-09-012015-12-01
Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma
Ibrutinib - Primary Central Nervous Lymphoma, Intraocular Lymphoma
Phase 2CompletedThe Lymphoma Academic Research Organisation522015-09-012022-04-14
Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
Dasatinib - Non-Hodgkin's Lymphoma, Multiple
Phase 1TerminatedBarbara Ann Karmanos Cancer Institute82015-02-122020-03-16
Comparability of Keratometry of VERION Image Guided System With Established Measuring Devices
Slit lamp, Autorefractor, IOLMaster 500 - Healthy
Not applicableCompletedHeidelberg University1502015-02-012017-12-13
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma
Not applicableWithdrawnFred Hutchinson Cancer Center2015-02-012015-05-07
CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
6,8-bis(benzylthio)octanoic acid, bendamustine hydrochloride, rituximab - B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia
Phase 1TerminatedWake Forest University Health Sciences12014-12-012018-07-02
Rotation of an Intraocular Lens - HOYA Vivinex iSert P261
Intraocular Lens Implantation - Intraocular Lens
Not applicableCompletedMedical University of Vienna662014-10-062017-05-17
The Clinical Importance of Angle Alpha by Multifocal Intraocular Lenses.
Cataract surgery - IOL, Cataract
CompletedHospital Hietzing652014-10-012020-02-21

Showing 20 of 165. Sign in to see all of them.

Narrower conditions

Burkitt Lymphoma (136)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (135)  ·  Lymphoma, Large B-Cell, Diffuse (135)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (135)  ·  Lymphoma, Follicular (133)  ·  Lymphoma, Non-Hodgkin (133)  ·  Lymphoma, B-Cell, Marginal Zone (132)  ·  Lymphoma, Mantle-Cell (132)  ·  Lymphoma, Large-Cell, Immunoblastic (129)  ·  Lymphoma, Large-Cell, Anaplastic (125)  ·  Lymphoma, T-Cell, Cutaneous (125)  ·  Mycosis Fungoides (120)  ·  Sezary Syndrome (120)  ·  Immunoblastic Lymphadenopathy (119)

Broader conditions

Eye Neoplasms (165)  ·  Hemic and Lymphatic Diseases (165)  ·  Immune System Diseases (165)  ·  Immunoproliferative Disorders (165)  ·  Lymphatic Diseases (165)  ·  Neoplasms by Histologic Type (165)  ·  Neoplasms by Site (165)  ·  Neoplasms (148)  ·  Lymphoproliferative Disorders (143)  ·  Pathologic Processes (141)  ·  Pathological Conditions, Signs and Symptoms (141)  ·  Hematologic Diseases (140)  ·  Disease Attributes (139)  ·  Lymphoma, B-Cell (139)  ·  DNA Virus Infections (137)

Interventions

Rituximab (17)  ·  Cyclophosphamide (15)  ·  Peripheral Blood Stem Cell Transplantation (15)  ·  fludarabine phosphate (12)  ·  Whole-Body Irradiation (11)  ·  Cyclosporine (10)  ·  Etoposide (9)  ·  Mycophenolic Acid (9)  ·  Filgrastim (8)  ·  Methotrexate (8)  ·  Lenalidomide (7)  ·  Busulfan (6)  ·  Dexamethasone (6)  ·  Tacrolimus (6)  ·  Carboplatin (5)

Sponsors

National Cancer Institute (NCI) (32)  ·  Fred Hutchinson Cancer Center (14)  ·  City of Hope Medical Center (6)  ·  Memorial Sloan Kettering Cancer Center (6)  ·  Barbara Ann Karmanos Cancer Institute (5)  ·  Case Comprehensive Cancer Center (5)  ·  European Organisation for Research and Treatment of Cancer - EORTC (4)  ·  M.D. Anderson Cancer Center (4)  ·  National Institutes of Health Clinical Center (CC) (4)  ·  Northwestern University (4)  ·  Wake Forest University Health Sciences (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Mayo Clinic (3)  ·  OHSU Knight Cancer Institute (3)  ·  Roswell Park Cancer Institute (3)

Countries

United States (130)  ·  Italy (9)  ·  Germany (8)  ·  Canada (6)  ·  France (5)  ·  Belgium (4)  ·  Switzerland (4)  ·  United Kingdom (4)  ·  China (3)  ·  Slovakia (3)  ·  Turkey (Türkiye) (3)  ·  Greece (2)  ·  Israel (2)  ·  South Korea (2)  ·  Spain (2)

Top investigators

David Maloney (5)  ·  Ajay Gopal (3)  ·  Edward A. Neuwelt, MD (3)  ·  Shivaani Kummar, MD (3)  ·  Abhinav Deol, M.D. (2)  ·  Ann Woolfrey (2)  ·  David G. Savage, MD (2)  ·  Jorge Cortes, MD (2)  ·  Mario Sznol, MD (2)  ·  Michael J. Fisch, MD, MPH, FACP (2)  ·  Ramesh Ramanathan (2)  ·  Ryotaro Nakamura (2)  ·  Adam J. Esbenshade, MD (1)  ·  Adam Petrich, MD (1)  ·  Alan P. Venook, MD (1)

Results publications

PMID 32499241, PMID 11410496, PMID 12525530, PMID 14630685, PMID 15459300, PMID 16135477, PMID 16148284, PMID 16863926, PMID 17312328, PMID 18293016, PMID 18327587, PMID 18698002, PMID 19789320, PMID 19841031, PMID 21247755, PMID 22259028, PMID 22480131, PMID 23197589, PMID 23358983, PMID 23393050, PMID 24474568, PMID 26175532, PMID 26213141, PMID 26700120, PMID 26700123, PMID 26764356, PMID 26943915, PMID 27020837, PMID 27118452, PMID 28270022, PMID 28314788, PMID 29292843, PMID 29572391, PMID 29986852, PMID 30205939, PMID 30262659, PMID 31279304, PMID 31481800, PMID 31617432, PMID 33471202, PMID 33492438, PMID 34249763, PMID 34515338, PMID 36999619, PMID 40720747, PMID 42099442

NIH funding

P30CA015704 (11), P30CA016672 (4), U01CA062491 (4), U01CA099168 (4), P01CA078902 (3), P30CA006973 (3), P30CA015083 (3), P30CA022453 (3), P30CA033572 (3), P30CA072720 (3), U01CA062505 (3), U01CA097452 (3), N01CM62202 (2), P01CA018029 (2), P30CA012197 (2)